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The deletion of the cellular form of the prion protein (PrPC) in mouse, goat, and
cattle has no drastic phenotypic consequence. This stands in apparent contradiction
with PrPC quasi-ubiquitous expression and conserved primary and tertiary structures in
mammals, and its pivotal role in neurodegenerative diseases such as prion and Alzheimer’s
diseases. In zebrafish embryos, depletion of PrP ortholog leads to a severe loss-of-function
phenotype. This raises the question of a potential role of PrPC in the development of all
vertebrates. This view is further supported by the early expression of the PrPC encoding
gene (Prnp) in many tissues of the mouse embryo, the transient disruption of a broad
number of cellular pathways in early Prnp−/− mouse embryos, and a growing body of
evidence for PrPC involvement in the regulation of cell proliferation and differentiation in
various types of mammalian stem cells and progenitors. Finally, several studies in both
zebrafish embryos and in mammalian cells and tissues in formation support a role for
PrPC in cell adhesion, extra-cellular matrix interactions and cytoskeleton. In this review,
we summarize and compare the different models used to decipher PrPC functions at early
developmental stages during embryo- and organo-genesis and discuss their relevance.
Keywords: prion protein, development, neural development, stem cells, cell adhesion, extra-cellular matrix,
cytoskeleton
INTRODUCTION
Prion diseases are a group of fatal and transmissible neurodegen-
erative diseases affecting a broad range of mammals including
humans. The causative agent (the prion) is primarily com-
posed of abnormally folded and aggregated forms of a host-
encoded protein, the cellular prion protein (PrPC). PrPC is a
glycosyl-phosphatidyl-inositol anchored cell surface sialoglyco-
protein associated with lipid rafts (Taylor et al., 2009). PrP pri-
mary sequence is highly conserved among mammals (Wopfner
et al., 1999) and PrP putative functional domains are structurally
conserved between mammals, avians, and fish (Wopfner et al.,
1999; Rivera-Milla et al., 2006). PrPC is widely expressed in nearly
all the organism, albeit at highest levels in the adult nervous sys-
tem (Bendheim et al., 1992). Together, these data lend support for
an essential role of PrPC in mammals and possibly in vertebrates
in general. However, the production of mice, goat, and cattle lack-
ing PrP did not lead to any obvious phenotype (Bueler et al., 1992;
Manson et al., 1994a; Richt et al., 2007; Yu et al., 2009) except, for
mice, a resistance to experimental prion diseases (Bueler et al.,
1993; Prusiner et al., 1993; Manson et al., 1994b; Mallucci et al.,
2003). Additionally, goats, naturally devoid of PrPC due to a non-
sense mutation, do not seem to present any abnormal phenotype
(Benestad et al., 2012). Subtle behavioral and oxidative stress-
related alterations have been then reported in adult mice devoid of
PrPC (see Table 1) (Tobler et al., 1996; Wong et al., 2001; Roucou
et al., 2004; Meotti et al., 2007; Sanchez-Alavez et al., 2008; Le
Pichon et al., 2009; Gadotti et al., 2012) although some of them
are debated (Steele et al., 2007) and some may be related to Prnp-
flanking genes rather than to PrPC absence itself (Nuvolone et al.,
2013). However, none of them seems, at first glance, so impor-
tant to justify the conserved structure and broad expression of
PrPC. The physiological role of PrPC still remains highly uncer-
tain despite more than two decades of research and numerous
proposed functions (Nicolas et al., 2009; Martins et al., 2010).
To conciliate these discrepant data, it has been hypothesized that
PrPC function is either dispensable or redundant with that of
other proteins. Yet, recent advances, notably in the developmen-
tal biology, shed a new light on PrPC functions and suggest that,
perhaps, the quest for PrPC functions has been made at the wrong
place and/or at the wrong period of time.
EARLY DEVELOPMENTAL EXPRESSION OF THE PrP GENES
IN SELECTED VERTEBRATES
The apparent lack of a phenotype in mice invalidated for PrPC
sounds at odds with the very early and quasi-ubiquitous expres-
sion pattern of the protein at embryonic and postnatal stages,
respectively. Expression of the gene encoding PrP—Prnp—is
detected in post-implantation embryo from embryonic day (E)
6.5 in extra-embryonic regions (Manson et al., 1992) and from
E7.5 (late allantoic bud stage) in cardiac mesoderm (Hidaka
et al., 2010). Prnp expression is then observed in the develop-
ing central nervous system and heart around E8 before extending
rapidly almost to the entire embryo (Tremblay et al., 2007).
Prnp may even be expressed earlier on as PrP mRNAs have been
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Table 1 | Phenotypes associated to PrP invalidation/ectopic activation.
Life
period/developmental
stage
Type of manipulation Phenotype(s) Comments References
Early embryo
(zebrafish) PrP-1 knockdown
Lethal
– gastrulation arrest due to
impaired cell adhesion
– partial rescue of the
morphants by the
injection of PrP mRNA
including mammalian
sequence
Malaga-Trillo et al., 2009
Early embryo (mouse)
Prnp knockout embryos
Moderately severe
– transcriptomic analysis shows
differential expression of genes
from multiple cell pathways
– transient phenotype Khalife et al., 2011;
Passet et al., 2012
Early embryo (mouse) PrP and Shadoo
co-invalidation obtained by:
Sprn knockdown and Prnp
knockout
Double knockout
Controversial
– impaired trophoblast
development, lethality
– no phenotype reported but no
assessment at embryonic stage
– discussed in Makhzami
et al. (2014)
Young et al., 2009;
Passet et al., 2012
Daude et al., 2012
Pharyngula stage
(zebrafish) PrP-2 knockdown
PrP-2 knockout
Controversial
– differential expression of genes
involved in multiple cell pathways
– no obvious developmental
abnormalities but no
transcriptomic analysis performed
– no phenotype rescue of
the morphants
Nourizadeh-Lillabadi
et al., 2010
Fleisch et al., 2013
Larva (zebrafish)
PrP-2 knockdown
PrP-2 knockout
Controversial
– head malformations, missing
neuronal structures
– no obvious abnormalities at larval
stage
– no phenotype rescue of
the morphants
Malaga-Trillo et al., 2009;
Nourizadeh-Lillabadi
et al., 2010
Fleisch et al., 2013
Late embryo/newborn
(mouse) Prnp knockout embryos
Minor
– increased proliferation and
maturation delay of the
oligodendrocyte precursor cell
population in the brain
– earlier formation of dentin and
enamel in the developing tooth
– no brain abnormalities
or myelin defect
– no enamel defect but
reduced hardness of
dentin at adult stage
Bribian et al., 2012
Zhang et al., 2011
Juvenile (mouse)
Prnp knockout mice
Moderately severe
– functional abnormalities and
persisting cell proliferation in the
cerebellum, impaired locomotor
abilities
– transient phenotype Prestori et al., 2008
Adult Brain (mouse)
Prnp knockout mice
Minor
– transcriptomic and proteomic
analysis revealed no important
differences
– increased protein oxidation,
protein ubiquitination and lipid
peroxidation
– increased proliferation and
maturation delay of the
oligodendrocyte precursor cells
– delayed maturation of astrocytes
– no brain abnormalities
or myelin defect
associated
Crecelius et al., 2008;
Chadi et al., 2010
Wong et al., 2001
Bribian et al., 2012
Arantes et al., 2009
(Continued)
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Table 1 | Continued
Life
period/developmental
stage
Type of manipulation Phenotype(s) Comments References
– decreased cell proliferation in the
dentate gyrus (adult neurogenic
region)
– functional abnormalities in the
hippocampus
Steele et al., 2006
Collinge et al., 1994
Adult brain (mouse)
Prnp overexpressing mice
Minor
– increased cell proliferation in the
subventricular zone (adult
neurogenic region)
– shorten astrocyte maturation
phase
– no brain abnormalities
associated
Steele et al., 2006
Hartmann et al., 2013
Adult extraneural
tissues (mouse) Prnp knockout mice
Minor
– delayed mineralization of the
continuously erupting incisors
– slower regeneration of muscle
fibers
– shortening of intestinal villi, cell
cycle alterations in intestinal
crypts and reduced size of
desmosomes in intestinal
epithelium
– regeneration and
renewing tissues
Zhang et al., 2011;
Stella et al., 2010
Morel et al., 2008
Adult (mouse)
Prnp knockout mice
Minor and/or partially
controversial
– depending of the study, no
phenotype observed to minor
alterations such as altered
olfactory behavior
– few studies were
carried out using distinct
genetic background
Bueler et al., 1992;
Collinge et al., 1994;
Tobler et al., 1996; Walz
et al., 1999; Nico et al.,
2005; Meotti et al., 2007;
Sanchez-Alavez et al.,
2008; Le Pichon et al.,
2009; Gadotti et al., 2012;
Rial et al., 2014
Adult (zebrafish)
PrP-2 knockout
Minor
– increased susceptibility to a
convulsant drug
– kinetics alteration of NMDA
receptors
Fleisch et al., 2013
Adult (zebrafish) PrP-1 knockout Unknown – no transgenic
(inducible) line
established
Aged animal (mouse)
Prnp knockout mice
Minor
– behavior alterations
Rial et al., 2009;
Massimino et al., 2013
Aged animal nerves
(mouse) Prnp knockout and
conditional Prnp knockout
Minor
– increased myelin abnormalities in
peripheral nerves
– several genetic
background analyzed
Bremer et al., 2010
found maternally expressed in the zygotes of Xenopus laevis and
zebrafish (Danio rerio) (van Rosmalen et al., 2006; Malaga-Trillo
et al., 2009).
Two PrP homologs, PrP-1, PrP-2 and a more divergent form,
PrP-3, have been identified in zebrafish (Cotto et al., 2005;
Rivera-Milla et al., 2006). The expression patterns of the cor-
responding genes (PrP-1, PrP-2, and PrP-3, respectively) in
zebrafish embryos are partially conflicting (Cotto et al., 2005;
Malaga-Trillo et al., 2009) although both studies agree on their
spatio-temporal complementarity. Both studies describe early PrP
www.frontiersin.org October 2014 | Volume 2 | Article 58 | 3
Halliez et al. To develop with or without the prion protein
gene expression from the mid-blastula stage although it is PrP-2
according to the Cotto et al. study and PrP-1 according toMalaga-
Trillo et al. At pharyngula stage (24–48 h postfertilization), both
studies show a strong and broad expression of PrP-2 in the devel-
oping central nervous system. Additionally, the Cotto et al. study
reports the expression of PrP-1 in the floor plate, an essential
organizing center of the central nervous system and in the periph-
eral nervous system around the same developmental period. The
expression of PrP-2 and PrP-3 in the developing neuromasts (sen-
sory organs) is also described at the larval stage. PrP-encoding
genes are also expressed in developing organs or tissues outside
the nervous system such as the heart (PrP-2 and PrP-3), the kid-
ney (PrP-2), the pectoral fins (PrP-2 and PrP-3) and the intestinal
epithelium (PrP-2) (Cotto et al., 2005).
THE EMBRYO SPILLS THE BEANS
In sharp contrast with the situation in mammals, knockdown
(KD) of PrP-1 or PrP-2 by morpholino injection led to severe
biological phenotypes in zebrafish (see Table 1): gastrulation
arrest for PrP-1 KD (Malaga-Trillo et al., 2009) and malforma-
tions of the brain and the eyes associated to a reduced num-
ber of peripheral neurons for PrP-2 KD (Malaga-Trillo et al.,
2009; Nourizadeh-Lillabadi et al., 2010). However, PrP-2 KD-
induced phenotype is subject to caution as PrP-2 knockout (KO)
by zinc finger nuclease-induced targeted mutation did not lead
to any obvious developmental phenotype (Fleisch et al., 2013).
Additional and aspecific effects due to morpholino injection may
have occurred. There is less concern about PrP-1 KD phenotype
as partial rescue was obtained by the injection of PrP-1 mRNA,
PrP-2mRNA and, remarkably, mouse PrnpmRNA (Malaga-Trillo
et al., 2009), strongly suggesting that zebrafish and mammalian
PrPs may share conserved functions.
PrP inactivation studies in zebrafish allow investigating PrPC
functions. They also favor a more critical role of PrPC in
early development rather than during postnatal stages (see
Table 1). Accordingly, transcriptomic analyses (by RNAseq) of
Prnp−/− versus wild-type mouse embryos identified numer-
ous genes differentially expressed (73 and 263 genes at E6.5
and E7.5, respectively) (Khalife et al., 2011), while only 1 gene
was found differentially expressed in adult brains (Chadi et al.,
2010). Proteomic analysis also failed to identify major alterations
(Crecelius et al., 2008) althoughmany cellular stress markers such
as protein oxidation, protein ubiquitination, and lipid peroxida-
tion were reportedly activated in the brains of Prnp−/− versus
wild-type mice (Wong et al., 2001). This suggests either that PrPC
is quite dispensable in the adult brain or that, in a Prnp−/−
context, alternative mechanisms are activated during the brain
development to compensate the absence of PrPC. Supporting the
second hypothesis, the number of genes differentially expressed
in the adult Prnp−/− mouse brain was substantially higher upon
postnatal depletion in neurons than embryonically (Chadi et al.,
2010), albeit to a less extent than in the embryo. The genes dif-
ferentially expressed in the embryo covered various cell functions
including adhesion, apoptosis and proliferation and are related
to heart formation and blood vessel development, vascular dis-
eases, immune response, nervous system development, and prion
diseases (Khalife et al., 2011). Interestingly and in line with the
idea of evolutionary conserved functions of PrPs, similar biologi-
cal functions were impacted by PrP-2 KD in zebrafish, as revealed
by transcriptomic analyses: development including that of the
cardiovascular and nervous systems specifically, cell death, cellu-
lar assembly, cell cycle, immunological, and neurological diseases
(Nourizadeh-Lillabadi et al., 2010).
Finally, the KD of the Sprn gene encoding a PrP-related pro-
tein, Shadoo resulted in embryonic lethality between E8 and
E11 specifically in Prnp−/− embryos, supporting a role for PrPC
and Shadoo in mouse embryogenesis, notably cell adhesion and
placenta development, and a possible functional redundancy
between the two proteins (Young et al., 2009; Passet et al., 2012).
However, the recent generation of viable Prnp−/−; Sprn−/− ani-
mals is challenging this view (Daude et al., 2012). These appar-
ently conflicting observations are discussed in Makhzami et al.
(2014).
Thus, studying the consequences of PrP inactivation during
developmental stages rather than in adult animals could be amore
efficient, although not easier, strategy to decipher PrPC func-
tions. Additionally, studying PrPC implications in regenerative
processes and in renewing tissues could also be an informative
approach (see Table 1).
THE CURRENT LIMITS OF IN VIVO STUDIES IN MAMMALS
As PrPC is mediating neuronal dysfunction and degeneration
in prion diseases and reportedly in Alzheimer’s disease (Lauren
et al., 2009; Klyubin et al., 2014), it has been logically suspected
to play a role in neuronal homeostasis and during neural devel-
opment. As PrPC functions in mature neurons are not under the
scope of the present review, we will not discuss them and only
focus on developmental aspects. In vivo direct evidence support-
ing a role of PrPC in neural development is quite elusive and PrPC
expression pattern remains one of the strongest pro arguments.
Indeed, PrPC expression increases as neurons mature, although it
is not detected in mitotically active neural progenitor cells (Steele
et al., 2006; Peralta et al., 2011). Other experimental evidence
was obtained from the comparative study of WT and Prnp−/−
and/or Prnp overexpressing animals (see Table 1). The levels of
PrPC were found to positively regulate the proliferation in neu-
rogenic regions in adult mice (Steele et al., 2006; Bribian et al.,
2012) and the maturation of astrocytes in the developing brain
(Arantes et al., 2009; Hartmann et al., 2013). Conversely, the
absence of PrPC was associated with an increased proliferation
in oligodendrocyte precursor cells both in embryos and adults
(Bribian et al., 2012). However, no brain morphology abnormal-
ities or myelin defects could be observed in Prnp−/− animals,
casting doubt on a crucial role of PrPC in cell proliferation and
maturation during brain development or, at least, suggesting the
occurrence of compensatory mechanisms. Yet, electrophysiolog-
ical recordings on hippocampus from Prnp−/− mice (Collinge
et al., 1994) and on cerebellum from juvenile Prnp−/− mice
(Prestori et al., 2008) revealed functional alterations. However,
no hippocampus-related behavioral or learning alterations were
observed in Prnp−/− mice (Bueler et al., 1992) suggesting the
hippocampus functional alterations areminor or at least compen-
sated. Conversely, cerebellum functional alterations were found
associated to a failure of juvenile Prnp−/− mice in motor control
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test and to protracted cell proliferation in the cerebellum granular
layer at the third week of postnatal development although all these
abnormalities vanished in older animals (Prestori et al., 2008).
Taken together, these arguments suggest a delay in the maturation
of the cerebellar granule cells in Prnp−/− mice.
Further dissecting the underlying mechanisms responsible for
the subtle phenotypes in Prnp−/− mice is a particularly arduous
task in vivo. For example, determining whether the effects are cell-
autonomous would require the use of several transgenic lines or
genetic chimeras to limit the expression of PrPC to a subset of
cells. And this question is far from being irrelevant as PrPC is a cell
surface protein. Such topology could elicit specific cell responses
in neighboring cells. Additionally, PrPC may act at distance since
secreted forms of have been described both in vitro and in vivo
(Borchelt et al., 1993; Harris et al., 1993).
CONTRIBUTIONS OF IN VITRO AND EX VIVO MODELS TO
UNDERSTANDING THE ROLE OF PrPC IN NEURAL
DEVELOPMENT
The use of in vitro or ex vivo models has generated a wealth of
data with regard to the involvement of PrPC in neural devel-
opment and, importantly, has comforted the putative functions
suggested by the in vivo approaches. Moreover they often allow
pinpointing more precisely the cellular processes and signaling
pathways involving PrPC. Collectively, these experimental data
argue that PrPC positively regulates (1) the differentiation of
pluripotent progenitors cells toward the neural lineage (Peralta
et al., 2011), (2) the proliferation of neural progenitor cells
(Prodromidou et al., 2014) (3) the self-renewal of neural pro-
genitor cells (Santos et al., 2011; Prodromidou et al., 2014) (4)
the neuronal differentiation in terms of choice of cell fate (Steele
et al., 2006) and (5) acquisition of neuronal features (Graner
et al., 2000). However, how PrPC fulfills these different actions is
only partially understood. The current idea is that PrPC is part of
multiprotein signaling complexes, able to bind various partners,
and participate to signal transduction events along different cel-
lular pathways depending on the cellular context (Caughey and
Baron, 2006; Watts et al., 2009; Stuermer, 2011; Hirsch et al.,
2014). Non-exhaustively, the interaction between PrPC and one
of its identified ligand, Stress inducible protein 1 (STI1), has
been shown to promote the self-renewal of the neural progeni-
tor cells (Santos et al., 2011). Besides, interaction with the neural
cell adhesion molecule (NCAM) can induce their neuronal dif-
ferentiation (Prodromidou et al., 2014). In cultured neurons,
STI1 binding to PrPC increases protein synthesis (Roffe et al.,
2010), STI1 and Laminin-γ1 binding promotes intracellular Ca2+
increase and axonogenesis (Santos et al., 2013), and vitronectin
binding, axonal growth (Hajj et al., 2007). Experimental evi-
dence also favors a role of PrPC in glia development since the
lack of PrPC promotes the proliferation of oligodendrocyte pre-
cursor cells and delays their differentiation in culture (Bribian
et al., 2012). Studies in astrocyte primary cultures revealed that
the involvement of PrPC in astrocytes maturation is dependent
upon its interaction with STI1 and the downstream activation
of ERK1/2 (Arantes et al., 2009). Of note, PrPC action does not
necessarily rely on PrPC expression solely in the cell population
considered. For instance, proper neuritogenesis has been shown
to require PrPC expression in both neurons and surrounding
astrocytes in co-cultures experiments (Lima et al., 2007). Beyond
a role in the interactions between both populations, PrPC serves
as a neuronal receptor for laminin (Graner et al., 2000) and is
also involved in the organization of the extracellular matrix by
the astrocytes, especially through laminin deposition (Lima et al.,
2007).
It should also be stressed that PrPC partners and the cel-
lular context could tightly determine the final consequences of
PrPC stimulation. For example PrPC interaction with contactin-
associated protein (Caspr) protects Caspr from proteolysis allow-
ing it to inhibit more efficiently neurite outgrowth (Devanathan
et al., 2010). On the opposite, PrPC and NCAM interactions
allow stabilization of NCAM in lipid rafts allowing Fyn kinase
activation and promoting neurite outgrowth (Santuccione et al.,
2005).
In vitro, PrPC is thereby found involved in all the major steps
of neural development. Since it notably regulates the self-renewal
and differentiation processes in neural progenitor cells, the ques-
tion arises as to whether this role can be extended to other cell
types.
WHAT THE STUDY OF STEM CELLS REVEALS
The role of PrPC is far from being restricted to neural develop-
ment and a growing body of evidence support its involvement in
stem cell biology see also Martin-Lannerée et al. (2014). Whether
PrPC is expressed in embryonic stem cells (ESC) at basal state
remains unclear (Lee and Baskakov, 2010; Miranda et al., 2011),
possibly due to limitations in the sensitivity of the detection
methods, choice of the target (i.e., the gene or the protein itself)
and methods of production and culture of the cells. Nevertheless,
there is a consensus that PrPC expression progressively increases
during stem cell differentiation (Miranda et al., 2011; Lee and
Baskakov, 2013). To understand the role played by PrPC during
early embryogenesis, the consequences of Prnp KD or overex-
pression were studied in human ESC (Lee and Baskakov, 2013).
Forcing PrPC expression under self-renewal conditions was found
to alter cell cycle regulation and to promote ESC differentia-
tion. Blocking PrPC expression in differentiating ESC also impacts
on cell cycle regulation and inhibits the differentiation toward
ectodermal lineages, in line with PrPC functions in neural dif-
ferentiation (Peralta et al., 2011) and the reduced expression of
Nestin, an ectodermal marker, observed in ESC in the absence of
PrPC (Miranda et al., 2011; Peralta et al., 2011). Mesodermal and
endodermal differentiations were, however, not affected. Finally,
overexpressing PrPC in differentiating ESC promotes prolifera-
tion and inhibits differentiation toward all the lineages (Lee and
Baskakov, 2013).
Further supporting PrPC function in stem cell biology, PrPC
is expressed in hematopoietic stem cells and promotes their self-
renewal (Zhang et al., 2006). PrPC is therefore involved in the
self-renewal and differentiation of stem cells although its role
and requirement seem to vary along the differentiation process
and the cell lineage considered. Identifying the molecular mecha-
nisms at play is a particularly challenging task since self-renewal,
differentiation and proliferation are highly intertwined processes
impacting each other.
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THE ROLE OF PrPC IN DEVELOPING AND RENEWING
TISSUES OUTSIDE THE NERVOUS SYSTEM
Looking outside the central nervous system in newborn to
full-grown animals allowed pinpointing subtle phenotypes in
the absence of PrPC (see Table 1), in perfect consistency with
PrPC widespread expression. PrPC is expressed in developing
human and murine teeth and study of dental cell cultures and
teeth from Prnp−/− animals revealed multiple alterations dur-
ing tooth formation (Schneider et al., 2007; Zhang et al., 2011).
In vitro, embryonic dental mesenchymal cells from Prnp−/−
embryos proliferate more rapidly and differentiate earlier and
coherently, Prnp−/− newborn mice exhibit earlier formation
of mesenchymally- and epithelially-derived dentin and enamel,
respectively (Zhang et al., 2011).
PrPC is also abundantly expressed in muscles and, although
no abnormalities could be observed in a physiological context, it
is involved in the regeneration of skeletal muscles in adult mice.
Regeneration of locally damaged muscle fibers occurs at slower
pace in Prnp−/− animals. Yet total recovery is finally achieved
(Stella et al., 2010). This is associated with a longer phase of pro-
liferation and a delayed maturation of muscle precursors, likely
due to a reduced level of released myogenic factors (Stella et al.,
2010). However, the identity of the releasing cells is difficult to
establish, showing again the limits of the in vivo paradigm.
Another extra-neural tissue where PrPC depletion induces
alterations is the intestinal epithelium, a constantly renewing tis-
sue. PrPC is expressed by human enterocytes (Morel et al., 2004)
and Prnp−/− animals exhibit shorter intestinal villi associated to
an increased number of mitotic cells (Morel et al., 2008).
Collectively, these observations support a role of PrPC in the
regulation of cell cycle and cell differentiation extraneurally. But
how can these functions be exerted?
PrPC REGULATES CELLULAR ADHESION, EXTRA-CELLULAR
MATRIX INTERACTIONS, AND CYTOSKELETON
REMODELING
PrP-1 KD-induced gastrulation arrest in zebrafish embryos is
due to impaired morphogenetic cell movements. This defect
is, at least partially, caused by the disruption of cellular adhe-
sion (Malaga-Trillo et al., 2009). The study revealed that PrP-1
normally accumulates at cell-cell contacts at early embryonic
stages and regulates cell adhesion, including E-cadherin process-
ing and/or storage, in a cell-autonomous way. Such functions may
be conserved in mammals as injection of mouse mRNA Prnp par-
tially rescued the PrP-1 KD-induced phenotype (Malaga-Trillo
et al., 2009). Consistent with this idea, a number of experimental
evidence have linked PrPC to cell adhesion and intimately associ-
ated processes such as cytoskeleton remodeling and interactions
with extra-cellular matrix (Petit et al., 2013): (i) the expression
pattern of PrPC. PrPC is expressed at the cell-to-cell contacts,
growth cone, and other extending process tips in cultured neural
progenitors and neurons (Santuccione et al., 2005; Devanathan
et al., 2010;Miyazawa et al., 2010), cell-to-cell junctions in human
intestinal epithelium villi (Morel et al., 2004), cell-to-cell con-
tacts in primary cultured endothelial cells (Viegas et al., 2006),
focal adhesions in HeLa cell lines (Schrock et al., 2009) and
the apical face of ameloblasts of developing teeth (Zhang et al.,
2011); (ii) relevant PrPC partners and ligands, such as cell junc-
tion proteins including integrins, the cytoskeleton protein actin
and components of the extra-cellular matrix (Graner et al., 2000;
Schmitt-Ulms et al., 2001; Morel et al., 2004, 2008; Nieznanski
et al., 2005; Hajj et al., 2007; Watts et al., 2009); (iii) alterations
in cell adhesion, cytoskeleton dynamics, and extra-cellular matrix
interactions upon ectopic expression or deletion of PrPC in dif-
ferent cell systems. Prnp KD leads to alterations in the actin
cytoskeleton, remodeling of focal adhesions and over-production
of fibronectin in neuronal progenitors (Loubet et al., 2012), to
disruption of adherens junctions in carcinoma cells (Solis et al.,
2012) and to miss-localization of cell junction-related proteins
in enterocytes (Morel et al., 2008). As for Prnp overexpression,
it promotes aggregation and filopodia formation as well as alter-
ations of the focal adhesion dynamics in neuroblastoma N2a cells
(Mange et al., 2002; Schrock et al., 2009). Subtle changes were
even noticed in vivo such as a decrease in the length of desmo-
somes in the intestinal epithelium of Prnp−/− mice (Morel et al.,
2008).
Interestingly, the alterations induced by the deletion of PrPC
can be partially rescued by neutralizing antibodies to specific
integrins: use of β1 and β5 integrins was found to restore neu-
ritogenesis in differentiating PrP-deficient neuronal progenitors
(Loubet et al., 2012) and Nanog expression in differentiating
PrP-deficient ESC (Miranda et al., 2011), respectively. Moreover,
modulation of integrin activity was suspected to be a spontaneous
compensatory mechanism occurring in the absence of PrPC (Hajj
et al., 2007). This last observation supports an involvement of
PrPC in extra-cellular matrix interactions and suggests a possible
adaptive mechanism to the absence of PrPC, which may account
for the lack of drastic phenotypes in Prnp−/− animals.
Taken together, these observations demonstrate a clear
involvement of PrPC in the regulation of cell adhesion, the
interactions with the extra-cellular matrix and the cytoskeleton
dynamics. The links between these functions and the role of PrPC
in the regulation of cell proliferation and differentiation have
been the focus of few studies (Miranda et al., 2011; Loubet et al.,
2012). Are they under-estimated? And are these functions still
ongoing in adult organism?
STUDYING PrPC FUNCTIONS DURING AGING
Little attention has been devoted to the potential functions of
PrPC during aging (see Table 1 and also Gasperini and Legname,
2014). It is commonly accepted that the cellular machinery dete-
riorates or, at least, evolves with aging. As the potential develop-
ment of adaptive mechanisms to the absence of PrPC is assumed
to complicate the study of PrPC functions in Prnp−/− mice, the
study of aged animals could be a way to bypass such difficulty:
because of the age-related alterations accumulation, the toler-
ance to PrPC depletion could partially break. In line with this
scenario, behavioral differences between WT and Prnp−/− mice
seem more pronounced when performed on aged animals (Rial
et al., 2009; Massimino et al., 2013). Age-related physiological
traits can also be found amplified in absence of PrPC. Myelin
abnormalities in the peripheral nervous system accumulate with
aging (Verdu et al., 2000) and sciatic nerves frommoderately aged
mice devoid of PrPC (in selected or all cell populations) showed
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highly precocious and increased demyelination in the absence of
neuronal PrPC (Bremer et al., 2010). If the axons-glia interactions
are known to play a key role in myelination during development
(Sherman and Brophy, 2005), their role in myelin maintenance in
adulthood is less well-understood. However, myelin maintenance
is clearly established as an active process (Bremer et al., 2011).
The early demyelination observed in the absence of neuronal
PrPC suggests axonal PrPC participates in myelin maintenance
and is likely required, directly or indirectly, in axons-Schwann
cells communication.
Thus, aging may perhaps be the ultimate stage to unravel the
mystery of PrPC function(s). However, it has to be considered
that aging could also impact on PrPC and/or its function(s). For
instance, the age-related change in the cholesterol/sphingolipids
ratio in lipid rafts is suspected to alter PrPC compartmentaliza-
tion (Agostini et al., 2013), which could ultimately impact on its
functions. A functional study of PrPC during aging could there-
fore be difficult to analyse due to the numerous changes occurring
at the same time.
CONCLUDING REMARKS
A major function of PrPC, consistent with its cell surface expres-
sion consists in the modulation of signaling pathways in response
to various cues. The panel of putative PrPC ligands is quite large,
including soluble ligands, extra-cellular matrix components, and
adhesion molecules. Their modes of interaction with PrPC are
variable, including cooperation (Santos et al., 2013) and both
cis- and trans-interactions for a same ligand (Santuccione et al.,
2005). The cellular context can strongly influence the compo-
sition of the PrPC-multiprotein complexes and the sub-cellular
localization of PrPC is highly dynamic: it can cycle rapidly from
the plasma membrane to internal membranes (Griffiths et al.,
2007) possibly in response to a given stimulus (Lee et al., 2001;
Brown and Harris, 2003; Caetano et al., 2008). All these elements
taken together may allow a specific response to a given signal with
regard to the cell type and differentiation state. This may explain
why PrPC appears to be involved in a multitude of functions.
Regarding development, this view perfectly fits the requirement
of different stem and progenitor cells by eliciting appropriate
cell responses to adapt efficiently to different microenviron-
ments. But how PrPC precisely impacts on stemness maintenance
and differentiation processes remains unresolved. The potential
implication of PrPC in cell polarization and cytoskeleton remod-
eling in differentiating stem cells is a very attractive hypothesis
and should obviously deserve further investigation. Cell polarity
and cytoskeleton dynamics are life-long important cell processes,
notably during cell fate determination. They have been studied
more particularly during drosophilia neurogenesis and in mam-
malian neuroepithelial cells (Fietz and Huttner, 2011), but they
are fundamental processes for all sort of stem and progenitor cells
such as hematopoietic progenitor cells (Bullock et al., 2007). Our
unpublished data (Halliez et al., in preparation) reveal a polarized
expression of PrPC in neural and cardiovascular progenitor cells
of the developing mouse embryo and therefore are compatible
with such idea.
If PrPC is involved in so many cell lineages, understanding the
lack of drastic phenotype in PrPC-depleted animals remains an
ongoing issue. Yet, a modulation of the cell maturation phase
(generally delayed but also shortened) is consistently observed
in different models (Prnp KO but also KD and overexpression)
and may therefore be the general price to pay for the loss of
PrPC (see Table 1). This may have a more selective impact on
free-range than on laboratory animals (for example acquisition
of perfect motor control) and justify the high degree of PrP con-
servation through evolution. Moreover, building an organism
is a highly complex task requiring spatial and temporal fine-
tuning of a broad number of biological processes via multiple
regulatory networks. Cells, tissues and organs do not develop
separately along each other but rely on multiple interactions to
develop in a concerted, interconnected, and time-scheduled man-
ner. Partial redundancies into and between signaling pathways
ensure robustness to the system. That two or more proteins may
exert overlapping functions during development and therefore
allow tolerance to the loss of one of them is not unprecedented
(Yoon et al., 2005; Santamaria and Ortega, 2006; Nicolae et al.,
2007). Moreover, it is not unheard-of, notably in plants where
environment adaptation is largely studied, that redundant genes
in a regular context allow survival under environmental modifi-
cations and stress (Wu et al., 2002). Interestingly, PrP KO animals
seem to react differentially than WT animals to stressful situa-
tions (Nico et al., 2005) and to alcohol (Rial et al., 2014) and
show increased susceptibility to convulsant agents (Walz et al.,
1999; Fleisch et al., 2013) (see Table 1). The general function of
PrPC could be to facilitate responses to external stimulus/factors
at the cell- and at the organism-scale. Yet, laboratory animals are
raised in standardized and protective environment and are often
homogenous genetically. In such conditions, the time window to
apprehend the cell specific functions of PrPC may be restricted
to the developmental and perinatal phases, with so much infor-
mation provided and so much transformation occurring at the
same time.
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